Attached files
| file | filename |
|---|---|
| 10-K - 10-K - BIOSPECIFICS TECHNOLOGIES CORP | form10k.htm |
| EX-32.1 - EXHIBIT 32.1 - BIOSPECIFICS TECHNOLOGIES CORP | ex32_1.htm |
| EX-31.1 - EXHIBIT 31.1 - BIOSPECIFICS TECHNOLOGIES CORP | ex31_1.htm |
| EX-21.1 - EXHIBIT 21.1 - BIOSPECIFICS TECHNOLOGIES CORP | ex21_1.htm |
| EX-14.1 - EXHIBIT 14.1 - BIOSPECIFICS TECHNOLOGIES CORP | ex14_1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of BioSpecifics Technologies Corp. on Form S-8 (No. 333-160583) of our reports dated March 14, 2018, on our audits of the consolidated financial statements as of December 31, 2017 and 2016 and for each of the years in the three-year period ended December 31, 2017 and the effectiveness of BioSpecifics Technologies Corp.’s internal control over financial reporting as of December 31, 2017, which reports are included in this Annual Report on Form 10-K to be filed on or about March 14, 2018.
|
/s/ EisnerAmper LLP
|
|
|
EISNERAMPER LLP
|
|
|
New York, New York
|
|
|
March 14, 2018
|